A Gene Linked to Type 1 Diabetes May Work Differently Than Scientists Thought

Scientists have known for years that variations in a gene called ORMDL3 increase the risk of developing Type 1 diabetes. This gene sits in a region of DNA (17q12-q21) that has been linked to several autoimmune diseases. ORMDL3 normally helps regulate lipid chemistry, inflammation, stress responses inside cells, and immune function—all processes that seem relevant to Type 1 diabetes.

But knowing that a gene is associated with disease doesn't tell us exactly how it contributes to illness. Does it cause problems in insulin-producing beta cells? Does it affect immune cells that attack the pancreas? Or both? These are crucial questions for understanding disease and developing treatments.

Researchers took a direct approach: they used mice genetically prone to Type 1 diabetes and deleted the Ormdl3 gene specifically in beta cells—the insulin-producing cells that are targeted in Type 1 diabetes. They made this deletion before the immune system began attacking the pancreas, which allowed them to see whether removing the gene from beta cells alone would prevent or slow disease development.

The team then carefully tracked whether the mice developed diabetes, how their islets (insulin-producing clusters) looked under the microscope, insulin and proinsulin levels in the blood, and patterns of immune cell infiltration.

Removing ORMDL3 from beta cells made no difference. The mice developed diabetes at normal rates. Their pancreatic islets looked normal, their circulating insulin levels were expected, and immune cell infiltration and inflammation followed typical patterns.

These findings indicate that ORMDL3 function in beta cells alone is not necessary to trigger Type 1 diabetes in this preclinical model. The gene's role in diabetes risk must involve other cell types or mechanisms.

This study doesn't eliminate ORMDL3 from the Type 1 diabetes story—it refocuses it. The most likely next step is investigating whether ORMDL3's role in immune cells, not beta cells, drives the disease process. Scientists may also need to examine other genes in the same genetic region to understand the full picture of genetic risk at this location.

Findings like this are important reminders that association between a gene and disease doesn't automatically reveal the mechanism. Understanding exactly where and how a gene contributes to illness is essential work that informs future therapeutic strategies.

Source: Biochemistry and biophysics reports. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.